cDNA cloning and expression analysis of flounder p53 tumour suppressor gene

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 121, Issue 3, 1998, Pages 235-242

  Cachot, Jérôme ^a,b   Galgani, François ^a   Vincent, Françoise ^a  

^a IFREMER   (France)

^b UNIVERSITÉ DU HAVRE   (France)

Author keywords

cDNA molecular evolution; Flatfish; Gene expression; p53 tumour suppressor gene; Platichthys flesus

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PROTEIN P53;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA LIBRARY; FISH; FLOUNDER; GENE EXPRESSION; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; RAINBOW TROUT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

MAMMALIA; ONCORHYNCHUS MYKISS; PLATICHTHYS FLESUS; PLEURONECTIFORMES; PLEURONECTOIDEI; SALMONIDAE;

EID: 0031646869     PISSN: 03050491     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-0491(98)10133-5     Document Type: Article

References (44)

1. cdc2 kinase motif. Oncogene 1990;5:423-6.
2. Caron de Fromentel C, Pakdel F, Chapus A, Baney C, May P, Soussi T. Rainbow trout p53: cDNA cloning and biochemical characterization. Gene 1990;112:241-5.
3. Cheng R, Ford BL, O'Neal PE, Mathews CZ, Bradford CS, Thongtan T, Barnes DW, Hendricks JD. Zebrafish (Danio rerio) p53 tumor suppressor gene: cDNA sequence and expression during embryogenesis. Mol Mar Biol Biotechnol 1997;6:88-97.
4. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994;265:346-55.
5. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid gunanidium thiocyanate phenol-chloroform extaction. Anal Biochem 1987;162:156-9.
6. Clore GM, Omichinski JG, Sakaguchi K, Zambrano N, Sakamoto H, Appella E, Gronenbornu AM. High-resolution of the oligomerization domain of p53 by multidimensional NMR. Science 1994;265:386-91.
7. Cox LS, Midgley CA, Lane DP. Xenopus p53 is biochemically similar to the human tumor suppressor protein p53 and is induced upon DNA damage in somatic cells. Oncogene 1994;9:2951-9.
8. Cox LS, Hupp T, Midgley CA, Lane DP. A direct effect of activated human p53 on nuclear DNA replication. EMBO J 1995;14:2099-105.
9. Dessen P, Fondrat C, Alencien C, Mugnier C. Bisance: a french service for access to molecular sequences database. Comp Appl Biosci 1990;6:335-6.
10. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, Oren M. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 1989;86:8763-7.
11. Fields S, Jang SK. Presence of a potent transcriptional activating sequence in the p53 protein. Science 1990;249:1046-9.
12. Finlay CA, Hinds PW, Levine AJ. The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989;57:1083-93.
13. Flaman J-M, Frebourg T, Moreau V, Charbonnier F, Martin C, Ishioka C, Friend SH, Iggo R. A rapid PCR fidelity assay. Nucleic Acids Res 1994;22:3259-60.
14. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
15. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1998;90:595-606.
16. Hainaut P, Milner J. A structural role for metal ions in the 'wild-type' conformation of the tumor suppressor protein p53. Cancer Res 1993;53:1739-42.
17. Harlow E, Williamson NM, Ralston R, Helfman DM, Adams TE. Molecular cloning and in vitro expression of a cDNA clone for human cellular antigen p53. Mol Cell Biol 1985;5:1601-10.
18. Harris CC, Hollstein M. Clinical implications of the p53 tumor-suppressor gene. New Engl J Med 1993;329:1318-27.
19. Hoever M, Clement JH, Wedlich D, Montenarh M, Knöchel W. Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos. Oncogene 1994;9:109-20.
20. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sørlie T, Hovig E, Smith-Sørensen B, Montesano R, Harris CC. Database of p53 gene somatic mutations in human tumors and cell lines. Nuleic Acids Res 1994;22:3551-5.
21. Hupp TR, Lane DP. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harb Symp Quant Biol 1994;59:195-206.
22. Jeffrey PD, Gorina S, Pavletich NP. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 Angstroms. Science 1995;267:1498-502.
23. Kaghad M, Bonnet H, Yang A, Créancier L, Biscan J-C, Valent A, Minty A, Chalon P, Lellas J-M, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90:809-19.
24. Krause MK, Rhodes LD, van Beneden RJ. Cloning of the p53 tumor suppressor gene from the Japanese medaka (Oryzias latipes) and evaluation of mutational hotspots in MNNG-exposed fish. Gene 1997;189:101-6.
25. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 1996;274:948-53.
26. Lees-Miller SP, Sakaguchi K, Ullrich SJ, Appella E, Anderson CW. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 1992;12:5041-9.
27. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
28. Lin J, Wu X, Chen J, Chang A, Levine AJ. Functions of the p53 protein in growth regulation and tumor suppression. Cold Spring Harb Symp Quant Biol 1994;59:215-23.
29. Lin JY, Chen JD, Elenbaas B, Levine AJ. Several hydrophobic amino acids in the p 53 amino-terminal domain are required for transcriptional activation, binding to mdm2 and the adenovirus 5 E1B 55-kD protein. Genes Dev 1994;8:1235-46.
30. Louis JM, McFarland VW, May P, Mora PT. The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim Biophys Acta 1988;950:395-402.
31. Nelson JS. Fishes of the World, 3rd ed. New York: John Wiley, 1994.
32. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B. Mutations in the p 53 gene occur in diverse human tumor types. Nature 1989;342:705-8.
33. Oren M, Levine A. Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen. Proc Nail Acad Sci USA 1983;80:56-9.
34. Raycroft L, Hongyun W, Guillermina L. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 1990;249:1049-51.
35. Rogel A, Popliker M, Webb CG, Oren M. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors. Mol Cell Biol 1985;5:2851-5.
36. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
37. Soussi T, Caron de fromentel C, Méchali M, May P, Kress M. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene 1987;1:71-8.
38. Soussi T, Bègue A, Stehelin D, May P. Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. Nucleic Acids Res 1988;16:11383.
39. Soussi T, Caron de Fromentel C, May P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene 1990;5:945-52.
40. Soussi T, May P. Structural aspects of the p53 protein in relation to gene evolution: a second look. J Mol Biol 1996;260:623-37.
41. Thompson JD, Higgins DG, Gibson TJ, Clustal W. improving the sensitivity of progressive multiple sequence alignment through sequence weighting position specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-80.
42. Vethaak AD, Wester PW. Diseases of flounder Platichthys flesus in Dutch coastal and estuarine waters, with particular reference to environmental stress factors. II. Liver histopathology. Dis Aquat Org 1996;26:99-116.
43. Wang Y, Farmer G, Soussi T, Prives C. Xenopus laevis p53 protein: sequence-specific DNA binding, transcriptional regulation and oligomerisation are evolutionarily conserved. Oncogene 1995;10:779-84.
44. Winge T, Fleming JT. Genbank LFU43595, 1996.